Yazar "Tulek, N." için listeleme
-
The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media
Tanyel, E.; Coban, A. Y.; Fisgin, N. Tasdelen; Tulek, N. (Medknow Publications, 2010)In this study, in vitro activity of tigecycline (TIG) and ertapenem (ERT) against clinical isolates of Brucella melitensis and the effect of different media on in vitro test results were investigated. The in vitro effects ... -
Five-year surveillance of nosocomial infections in Ankara Training and Research Hospital
Erdinc, F. S.; Yetkin, M. A.; Hatipoglu, C. Ataman; Yucel, M.; Karakoc, A. E.; Cevik, M. A.; Tulek, N. (W B Saunders Co Ltd, 2006)The objective of this study was to assess the rate of nosocomial infections (NIs), frequency of nosocomial pathogens and antimicrobial susceptibility changes in a 530-bed hospital. over a five-year period. Hospital-wide ... -
Initial high rate of misdiagnosis in Crimean Congo haemorrhagic fever patients in an endemic region of Turkey
Fisgin, N. Tasdelen; Doganci, L.; Tanyel, E.; Tulek, N. (Cambridge Univ Press, 2010)Crimean Congo haemorrhagic fever (CCHF) has been an emerging tick-borne infection in some parts of Turkey since 2002, with a number of fatalities. Many of the initial non-specific symptoms of CCHF can mimic other common ... -
Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis
Coban, A. Y.; Tanyel, E.; Fisgin, N. Tasidelen; Darka, O.; Tulek, N.; Durupinar, B. (Taylor & Francis Ltd, 2007)… -
The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising
Fisgin, N. Tasdelen; Ergonul, O.; Doganci, L.; Tulek, N. (Springer, 2009)Crimean-Congo hemorrhagic fever (CCHF) is a disease with high fatality. To demonstrate the effectiveness of ribavirin against CCHF. The first group of 21 patients received ribavirin within 4 days of the onset of symptoms ... -
An unusual presentation of sirolimus associated cough in a renal transplant recipient
Adibelli, Z.; Dilek, M.; Kocak, B.; Tulek, N.; Uzun, O.; Akpolat, T. (Elsevier Science Inc, 2007)Sirolimus-associated pulmonary problems are rare but life threatening. Pulmonary problems due to sirolimus treatment are interstitial pneumonitis, bronchiolitis obliterans organizing pneumonia (BOOP), and alveolar hemorrhage. ...
